Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmuChem Pharma is a specialty chemical company and contract research organization (CRO) that provides high-quality reference standards to the pharmaceutical and biotech industries. The company specializes in the custom synthesis of stable isotope-labeled internal standards, including those labeled with Deuterium, Carbon-13, and Nitrogen-15. Additionally, they produce drug metabolites, impurities, and glucuronides necessary for bioanalytical and pharmacokinetic studies. Based in Canada, ImmuChem Pharma supports drug development programs by ensuring regulatory compliance through precise analytical characterization and high-purity chemical synthesis. Their products are essential for LC-MS/MS bioanalysis and other quantitative research applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMCHEM PHA.